Literature DB >> 5318574

Combined antibiotic therapy.

K Gal.   

Abstract

THE INDICATIONS FOR COMBINED ANTIBIOTIC THERAPY ARE REVIEWED, AND TWO MAJOR INDICATIONS ARE DISCUSSED AT LENGTH: the prevention of development of antibiotic resistance and the possibility of achieving antibiotic synergism.Since micro-organisms vary in their behaviour in the presence of different antibiotic combinations, careful evaluation of clinical response and close laboratory control are necessary.Antibiotics are divided into four groups and their possible combinations are described. It is emphasized that bactericidal antibiotics, e.g. penicillin and streptomycin, which act only on multiplying bacteria, may be antagonized by some bacteriostatic antibiotics, e.g. tetracycline. Clinical observations appear to confirm the usefulness of this division of the antibiotics.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5318574      PMCID: PMC1928965     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  Arrested protein synthesis increases persister-like cell formation.

Authors:  Brian W Kwan; John A Valenta; Michael J Benedik; Thomas K Wood
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Development of resistance to novobiocin, tetracycline, and a novobiocin-tetracycline combination in Staphylococcus aureus populations.

Authors:  J J Vavra
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

3.  Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Patrick Müller; Dagmar G Alber; Lynne Turnbull; Ralf C Schlothauer; Dee A Carter; Cynthia B Whitchurch; Elizabeth J Harry
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.